HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by BNP Paribas

BNP Paribas increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.7% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,770 shares of the company’s stock after purchasing an additional 456 shares during the quarter. BNP Paribas’ holdings in HCA Healthcare were worth $1,126,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. FMR LLC raised its holdings in shares of HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in HCA Healthcare in the second quarter valued at $131,527,000. Darsana Capital Partners LP increased its stake in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares during the last quarter. Swedbank AB acquired a new position in HCA Healthcare in the first quarter valued at $95,882,000. Finally, Argent Capital Management LLC increased its stake in HCA Healthcare by 1,215.6% in the second quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock valued at $51,493,000 after purchasing an additional 148,092 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on HCA shares. TD Cowen dropped their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Royal Bank of Canada boosted their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. KeyCorp lowered their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Finally, Oppenheimer upped their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $380.29.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 21.97 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,155 shares of company stock worth $5,608,990. 1.70% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 1.1 %

Shares of HCA Healthcare stock opened at $325.35 on Thursday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The business’s 50 day simple moving average is $374.98 and its 200-day simple moving average is $358.51. The stock has a market capitalization of $82.41 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 1.25 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.